2nd National ICE-T Congress
The 2nd National ICE-T (Immune Cell Effector Therapy) Congress is a specialized clinical conference focused on the latest advancements in cellular and bispecific therapies for hematologic and solid tumors. Scheduled […]
The 2nd National ICE-T (Immune Cell Effector Therapy) Congress is a specialized clinical conference focused on the latest advancements in cellular and bispecific therapies for hematologic and solid tumors. Scheduled […]
The 2026 Australian Pain Society 46th Annual Scientific Meeting (APS 2026) is Australia's leading multidisciplinary conference focused on the management and research of complex pain. The meeting is scheduled for […]
The 2026 World Indigenous Cancer Conference (W.I.C.C. 2026) is being hosted by the World Indigenous Cancer Network and Hei Āhuru Mōwai Māori (Cancer Leadership Aotearoa). The conference will be held […]
The 2026 World Indigenous Cancer Conference (WICC 2026) will be held from April 21 to 23, 2026, at Te Whare Tapere o Manukau (Due Drop Events Centre) in Auckland, New […]
NCCN will host a specialized tumor board session titled "Managing Unique Toxicities and Immune-Related Adverse Effects of Treatment for Hodgkin Lymphoma" on April 30, 2026, from 3:00 PM to 4:00 […]
The Lung Cancer Europe Conference 2026 is a dedicated advocacy and educational summit scheduled for April 22–24, 2026, in Vienna, Austria. This biennial event serves as a critical platform for […]
On April 22, 2026, NCCN will host a specialized clinical program titled "Optimizing Patient Outcomes - In a Blink of an Eye: Updates in Frontline Therapy with Blinatumomab for Pediatric […]
The ESMO Advanced Course on Early Stage Non-Small-Cell Lung Cancer 2026 is an intensive educational meeting scheduled to take place from April 23–24, 2026, in Athens, Greece. Under the leadership […]
The webinar titled "Escalation or de-escalation? Strategies in HER2+ breast cancer treatment" is scheduled to take place on April 23, 2026, at 18:00 CEST. Organized by OncoCorner and Sharing Progress […]
The OncoDaily Multiple Myeloma Congress 2026 is scheduled for April 23, 2026, as a virtual global congress streaming live on YouTube and X. This event addresses a global burden of […]
The "Oncology 101: An In-Depth Hematology and Oncology Review for Advanced Practice Providers" is a two-and-a-half-day virtual continuing education conference, presented by Horizon CME in partnership with APAO, scheduled for […]
The Canadian Association of Pharmacy in Oncology (CAPhO) Conference 2026 will be held from April 23–26, 2026, at TCU Place in Saskatoon, Saskatchewan. Centered on the theme "Expanding Horizons in the Land of Living Skies," this premier event explores the future of oncology pharmacy through the lenses of precision medicine, technological innovation, and an evolving […]
The Advocates Webinar: External Control Arms in Oncology Drug Development, a free virtual event hosted by Friends of Cancer Research, is scheduled for Tuesday, April 23, 2026, from 1:00 PM to 2:00 PM ET. This webinar is designed to build on the earlier public meeting by focusing on what External Control Arms (ECAs) - which […]
NCCN will host a virtual master class titled "Precision in Practice: A Master Class on PARPi Combinations, Testing Strategies, and Toxicity Management in Metastatic Prostate Cancer" on Thursday, April 23, 2026, from 6:00 PM to 7:30 PM ET. Featuring a distinguished panel of experts, this session is designed to help community oncologists, urologists, and the […]
The APPOS Cincinnati 2026 (Advanced Practice Providers Oncology Summit) is a two-day continuing education conference tailored for advanced practice providers (APPs), including NPs, PAs, pharmacists, and nurses, who are part of the multidisciplinary oncology team. The summit is scheduled for April 24–25, 2026, and will be held at The Westin Cincinnati Hotel in Cincinnati, Ohio. […]
The ALRCaN Global webinar, “Treatment Strategy for a 4-Year-Old Boy with Newly Diagnosed MLL-AF4-Positive B-ALL,” is set for Friday, April 24, 2026, from 09:00 AM to 10:00 AM ET (05:00 PM – 06:00 PM AMT). Led by Dr. Hisato Segoe, this session examines specialized clinical approaches for high-risk pediatric leukemia subtypes. Organized by the Acute […]